Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Phibro Animal Health (PAHC) EBIAT (2016 - 2025)

Phibro Animal Health (PAHC) has 13 years of EBIAT data on record, last reported at $27.5 million in Q4 2025.

  • For Q4 2025, EBIAT rose 762.14% year-over-year to $27.5 million; the TTM value through Dec 2025 reached $95.4 million, up 2347.03%, while the annual FY2025 figure was $48.3 million, 211.43% up from the prior year.
  • EBIAT reached $27.5 million in Q4 2025 per PAHC's latest filing, up from $26.5 million in the prior quarter.
  • Across five years, EBIAT topped out at $27.5 million in Q4 2025 and bottomed at -$27.3 million in Q2 2024.
  • Average EBIAT over 5 years is $10.0 million, with a median of $11.1 million recorded in 2021.
  • Peak YoY movement for EBIAT: crashed 733.68% in 2024, then soared 762.14% in 2025.
  • A 5-year view of EBIAT shows it stood at $23.5 million in 2021, then tumbled by 69.36% to $7.2 million in 2022, then plummeted by 82.33% to $1.3 million in 2023, then skyrocketed by 150.0% to $3.2 million in 2024, then soared by 762.14% to $27.5 million in 2025.
  • Per Business Quant database, its latest 3 readings for EBIAT were $27.5 million in Q4 2025, $26.5 million in Q3 2025, and $20.5 million in Q2 2025.